abstract |
This invention pertains to pharmaceutical formulations which comprise (i) a drug (e.g., doxorubicin) and (ii) a short-chain sphingolipid (e.g., N-octanoyl-glucosylceramide, N-hexanoyl-sphingomyelin) and which provide improved drug delivery and efficacy. |